CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus

REFERENCES

• Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol. 2001;75:7059–7066.
   PubMed Web of Science ®Google Scholar
• Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. 1999. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol. 1999;163:6236–6243.
   PubMed Web of Science ®Google Scholar
• Lechner F, Gruener NH, Urbani S, CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol. 2000;30:2479–2487.
   Google Scholar
• Lechner F, Cuero, AL, Kantzanou M, Klenerman P. Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers. Rev Med Virol. 11:11–22.
   Google Scholar
• Gruener NH, Lechner F, Jung MC, Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol. 2001;75:5550–5558.
   PubMed Web of Science ®Google Scholar
• Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol. 1996;157:3598–3604.
   Google Scholar
• Grayson MH, Holtzman MJ. Chemokine complexity: the case for CCL5. Am J Respir Cell Mol Biol. 2006; 35:143–146.
   Google Scholar
• Stanford MM, Issekutz TB. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J Leukoc Biol. 2003;74:791–799.
   PubMed Web of Science ®Google Scholar
• Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003; 37:1043–1055.
   Google Scholar
• Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88:125–172.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol. 2003;285:G949–G958.
   PubMed Web of Science ®Google Scholar
• Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C. Mediators Inflamm. 2004;13:357–359.
   Google Scholar
• Apolinario A, Majano PL, Alvarez-Perez E, Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol. 2002;97:2861–2870.
   PubMed Web of Science ®Google Scholar
• Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest. 2000;80:415–422.
   Google Scholar
• Wei XQ, Wen ZF, Zheng FP, Yao JL. [Changes of RANTES levels in livers of patients with chronic hepatitis B: the clinical significance and the possible mechanisms]. Zhonghua Gan Zang Bing Za Zhi. 2007;15:585–588.
   Google Scholar
• Katsounas A, Trippler M, Wang B, CCL5 mRNA is a Marker for early fibrosis in chronic hepatitis C and is regulated by Interferon-α therapy and Toll-like receptor 3 signaling. J Viral Hepat. In press.
   Google Scholar
• Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19:1409–1417.
   PubMed Web of Science ®Google Scholar
• Neuman MG, Benhamou JP, Marcellin P, Cytokine—chemokine and apoptotic signatures in patients with hepatitis C. Transl Res. 2007;149:126–136.
   PubMed Web of Science ®Google Scholar
• Berres ML, Koenen RR, Rueland A, Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest. 2010;120:4129–4140.
   PubMed Web of Science ®Google Scholar
• Leifeld L, Dumoulin FL, Purr I, Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol. 2003;199:335–344.
   PubMedGoogle Scholar
• Shebl FM, Pinto LA, Garcia-Pineres A, Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles. Cancer Epidemiol Biomarkers Prev. 2010;19:978–981.
   PubMed Web of Science ®Google Scholar
• Lin YU, Liu CC, Chuang JI, Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology. 2000;276:114–126.
   PubMed Web of Science ®Google Scholar
• Matikainen S, Pirhonen J, Miettinen M, Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology. 2000;276:138–147.
   Google Scholar
• Matsukura S, Kokubu F, Kubo H, Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol. 1998;18:255–264.
   PubMed Web of Science ®Google Scholar
• Soo HM, Garzino-Demo A, Hong W, Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology. 2002;303:253–277.
   Google Scholar
• Thomas LH, Friedland JS, Sharland M, Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J Immunol. 1998;161:1007–1016.
   Google Scholar
• Genin P, Algarte M, Roof P, Lin R, Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol. 2000; 164:5352–5361.
   PubMedGoogle Scholar
• Miller K, McArdle S, Gale MJ Jr, Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res. 2004;24:391–402.
   PubMedGoogle Scholar
• Losana G, Bovolenta C, Rigamonti L, IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. J Leukoc Biol. 2002; 72:735–742.
   PubMed Web of Science ®Google Scholar
• Manetti R, Parronchi P, Giudizi MG, Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 1993;177:1199–1204.
   Google Scholar
• Diepolder HM, Zachoval R, Hoffmann RM, Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995;346:1006–1007.
   PubMed Web of Science ®Google Scholar
• Fan XG, Liu WE, Li CZ, Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm.1998;7:295–297.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Ishii M, Igarashi T, Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C. J Gastroenterol. 1998;33:500–507.
   Google Scholar
• Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 1997;25:449–458.
   PubMed Web of Science ®Google Scholar
• Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol. 1997;159:1012–1018.
   PubMed Web of Science ®Google Scholar
• Rosen HR, Miner C, Sasaki AW, Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 2002;35:190–198.
   PubMed Web of Science ®Google Scholar
• Sobue S, Nomura T, Ishikawa T, Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol. 2001;36:544–551.
   PubMed Web of Science ®Google Scholar
• Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat. 2004;11:519–526.
   Google Scholar
• Solari R, Offord RE, Remy S, Receptor-mediated endocytosis of CC-chemokines. J Biol Chem. 1997;272:9617–9620.
   Google Scholar
• Ulsenheimer A, Gerlach JT, Gruener NH, Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology.2003;37:1189–1198.
   PubMed Web of Science ®Google Scholar
• Marfaing-Koka A, Devergne O, Gorgone G, Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol. 1995;154:1870–1878.
   PubMedGoogle Scholar
• Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat. 2007;14:675–687.
   PubMed Web of Science ®Google Scholar
• Hariharan D, Douglas SD, Lee B, Lai JP, Campbell DE, Ho WZ. Interferon-gamma upregulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood. 1999; 93:1137–1144.
   Google Scholar
• Zella D, Barabitskaja O, Burns JM, Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood. 1998; 91:4444–4450.
   PubMed Web of Science ®Google Scholar
• Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol. 2001;167:4345–4350.
   PubMed Web of Science ®Google Scholar
• Kanda T, Steele R, Ray R, Ray RB. Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice. J Virol. 2009;83:8463–8469.
   Google Scholar
• Pelchen-Matthews A, Signoret N, Klasse PJ, Fraile-Ramos A, Marsh M. Chemokine receptor trafficking and viral replication. Immunol Rev. 1999;168:33–49.
   PubMedGoogle Scholar
• Lichterfeld M, Leifeld L, Nischalke HD, Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis. 2002;185:1803–1807.
   Google Scholar
• Hellier S, Frodsham AJ, Hennig BJ, Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology. 2003; 38:1468–1476.
   PubMed Web of Science ®Google Scholar
• Promrat K, Liang TJ. Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders? Hepatology. 2003;38:1359–1362.
   PubMed Web of Science ®Google Scholar
• Lechner F, Wong DK, Dunbar PR, Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000;191:1499–1512.
   PubMed Web of Science ®Google Scholar
• Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395–1406.
   PubMed Web of Science ®Google Scholar
• Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol. 2008;14:7149–159.
   Google Scholar
• Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol. 2000; 12:403–408.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Yang JS, Dentchev T, Dang K, Weiner DB. Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J Interferon Cytokine Res. 2000;20:487–498.
   PubMed Web of Science ®Google Scholar
• Promrat K, McDermott DH, Gonzalez CM, Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology. 2003; 124:352–360.
   PubMed Web of Science ®Google Scholar
• An p, Nelson gw, Wang L, Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A. 2002;99:10002–10007.
   PubMed Web of Science ®Google Scholar
• Wasmuth HE, Werth A, Mueller T, Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C. Hepatology. 2004;40:327–334.
   Google Scholar
• McDermott DH, Beecroft MJ, Kleeberger CA, Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS. 2000;14:2671–2678.
   PubMed Web of Science ®Google Scholar
• Navratilova Z. Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150:191–204.
   PubMedGoogle Scholar
• Afford SC, Fisher NC, Neil DA, Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. 1998;186:82–89.
   PubMed Web of Science ®Google Scholar
• Zimmermann HW, Seidler S, Nattermann J, Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 5:e11049.
   Google Scholar
• Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 1996;24:759–765.
   PubMed Web of Science ®Google Scholar
• Leroy V, Vigan I, Mosnier JF, Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology. 2003;38:829–841.
   Google Scholar
• Tran A, Yang G, Doglio A, Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C. Dig Dis Sci. 1997;42:2495–500.
   Google Scholar
• Khakoo SI, Soni PN, Savage K, Lymphocyte and macrophage phenotypes in chronic hepatitis C infection: correlation with disease activity. Am J Pathol. 1997;150:963–970.
   PubMed Web of Science ®Google Scholar
• Barnaba V, Franco A, Paroli M, Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol. 1994;152:3074–3087.
   PubMed Web of Science ®Google Scholar
• Sun QL, Ran W. Review of cytokine profiles in patients with hepatitis. World J Gastroenterol.2004; 10:1709–1715.
   Google Scholar
• Dumoulin FL, Bach A, Leifeld L, Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis. 1997;175:681–685.
   Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med.1998; 187:129–134.
   PubMed Web of Science ®Google Scholar
• Loetscher P, Uguccioni M, Bordoli L, CCR5 is characteristic of Th1 lymphocytes. Nature.1998; 391:344–345.
   PubMed Web of Science ®Google Scholar
• Qin S, Rottman JB, Myers P, The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746–754.
   PubMed Web of Science ®Google Scholar
• Seki E, De Minicis S, Gwak GY, CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 2009; 119:1858–1870.
   PubMed Web of Science ®Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. Is it the end of the line for the EMT? Hepatology 2011 May;53(5):1433–1435.
   Google Scholar
• Dranoff JA, Wells RG. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology. 2010 Apr;51(4):1438–44. Review.
   PubMed Web of Science ®Google Scholar
• Bronfenmajer S, Schaffner F, Popper H. Fat-storing cells (lipocytes) in human liver. Arch Pathol. 1966;82:447–453.
   PubMedGoogle Scholar
• Bonacchi A, Petrai I, Defranco RM, The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology. 2003;125:1060–1076.
   PubMed Web of Science ®Google Scholar
• Marra F, Pinzani M. Role of hepatic stellate cells in the pathogenesis of portal hypertension. Nefrologia. 2002;22 (Suppl 5):34–40.
   Google Scholar
• Knittel T, Dinter C, Kobold D, Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol. 1999;154:153–167.
   PubMed Web of Science ®Google Scholar
• Shibuya K, Robinson D, Zonin F, IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol. 1998;160:1708–1716.
   PubMed Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2005;289:G571–G578.
   Web of Science ®Google Scholar
• Apte MV, Haber PS, Darby SJ, Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534–541.
   PubMed Web of Science ®Google Scholar
• Wang B, Trippler M, Pei R, Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol. 2009 Dec;51(6):1037–1045.
   PubMed Web of Science ®Google Scholar
• Kuntzen T, Tural C, Li B, Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS. 2008;22:203–210.
   Google Scholar
• Bica I, McGovern B, Dhar R, Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492–497.
   PubMed Web of Science ®Google Scholar
• Salmon-Ceron D, Lewden C, Morlat P, Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799–805.
   PubMed Web of Science ®Google Scholar
• Boisvert J, Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J Hepatol. 2003;38:67–75.
   PubMed Web of Science ®Google Scholar
• Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005;33:52–62.
   PubMed Web of Science ®Google Scholar
• Poynard T, Afdhal NH. Perspectives on fibrosis progression in hepatitis C: an a la carte approach to risk factors and staging of fibrosis. Antivir Ther. 2010;15(3):281–291.
   Google Scholar
• Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993;178:1655–1663.
   PubMed Web of Science ®Google Scholar
• Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology.1996; 24:6–9.
   PubMed Web of Science ®Google Scholar
• Martin J, Navas S, Quiroga JA, Pardo M, Carreno V. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine.1998; 10:635–644.
   Google Scholar
• Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T. Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol. 2003;64:497–504.
   Google Scholar
• Vertuani S, Bazzaro M, Gualandi G, Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. Eur J Immunol. 2002; 32:144–154.
   PubMed Web of Science ®Google Scholar
• Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology. 2000; 118:346–355.
   PubMed Web of Science ®Google Scholar
• Cremer I, Ghysdael J, Vieillard V. A non-classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs. FEBS Lett. 2002;511:41–45.
   Google Scholar
• Cremer I, Vieillard V, De Maeyer E. Retrovirally mediated IFN-beta transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression. J Immunol. 2000;164:1582–1587.
   Google Scholar
• Sanda C, Weitzel P, Tsukahara T, Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res. 2006; 26:462–472.
   Google Scholar
• Zimmerer JM, Lesinski GB, Radmacher MD, Ruppert A, Carson WE 3rd. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha. Cancer Immunol Immunother. 2007;56:1845–1852.
   Google Scholar
• Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol. 2001; 112:174–180.
   PubMed Web of Science ®Google Scholar
• Manns MP, McHutchison JG, Gordon SC, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958–965.
   PubMed Web of Science ®Google Scholar
• Yang YF, Tomura M, Iwasaki M, IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells. J Clin Immunol. 2001; 21:402–409.
   Google Scholar
• Foster GR, Masri SH, David R, IFN-alpha subtypes differentially affect human T cell motility. J Immunol. 2004;173:1663–1670.
   PubMedGoogle Scholar
• Lempicki RA, SJ, Masur H, Polis MA, Kottilil S. Genome-wide single polymorphism analysis identifies a unique CCL-5 haplotype in HIV/HCV co-infected non-responders to pegylated interferon (peg-IFN) and ribavirin (RBV) therapy [Abstract]. Hepatology. 2009; 50(Suppl):690A.
   Google Scholar